The current work extends these mechanistic observations to geriatric AF pathophysiology, demonstrating its capacity to orchestrate NAD+ metabolic rejuvenation via dual modulation of Nampt-mediated biosynthesis and PARP1-dependent catabolism. This evidence concerns the gene NAMPT and atrial fibrillation.